Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
TNGX
#1404
Tango Therapeutics, Inc. - Common Stock
21.9
8
USD
+9.90%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+9.90%
Monthly Change
-0.77%
6 month change
+105.61%
Year Change
+843.35%
Previous Close
20.0
0
Open
21.9
8
Low
21.9
8
High
21.9
8
Volume
173
Markets
US Stock Market
Healthcare
TNGX
Open full chart
Full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
21.38 M
87.71 M
88.2 M
106.72 M
108.11 M
142.69 M
144.65 M
Valuation ratios
Enterprise value
—
816.78 M
584.8 M
998.66 M
264.52 M
1.15 B
2.78 B
Price to earnings ratio
—
—
-5.94
-9.24
-2.6
-10.18
-24.5
Price to sales ratio
—
—
25.82
25.84
8.02
16.5
41.86
Price to cash flow ratio
—
—
5.89
8
2.57
-7.41
-17.56
Price to book ratio
—
—
2.57
3.73
1.69
2.97
2.45
Enterprise value to EBITDA ratio
—
-14.26
-5.34
-8.94
-1.85
-10.57
-24.11
Profitability ratios
Return on assets %
—
-0.12
-0.25
-0.25
-0.41
-0.25
-0.1
Return on equity %
—
-0.17
-0.43
-0.4
-0.65
-0.29
-0.12
Return on invested capital %
—
-222.9
-607.78
-467.22
-700.47
-808
-369.25
Gross margin %
—
100
100
100
100
100
—
Operating margin %
—
-157.09
-446.79
-312.57
-346.09
-178.39
—
EBITDA margin %
—
-154.67
-440.32
-305.96
-340.15
-174.74
—
Net margin %
—
-157.21
-435.14
-278.54
-309.73
-162.85
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
13.1
12.1
6.76
7.54
6.98
16.32
27.38
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
—
0.11
0.05
0.09
0.12
0.16
0
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
-1.24
-1.25
-1.2
-1.2
-1.16
EBIT per share
—
—
-1.26
-1.21
-1.33
-0.96
-0.95
EBITDA per share
—
—
-1.25
-1.18
-1.31
-0.94
-0.93
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
—
7.66
6.42
2.36
2.95
2.65
Net current asset value per share
—
—
4.27
3.66
2.44
3.05
2.73
Tangible book value per share
—
—
2.84
2.68
1.83
2.98
2.73
Working capital per share
—
—
3.64
3.18
2.09
2.86
2.63
Book value per share
—
—
2.84
2.68
1.83
2.98
2.73
News
Tango Therapeutics: 'Hold' On Combination Strategy Shift Of Vopimetostat (NASDAQ:TNGX)
RVMD Reports Wider-Than-Expected Loss in Q1, Raises '26 Expense View
Why This CEO Is Confident His Drug Can Top 'Unprecedented' Pancreatic Cancer Results
The 'Unprecedented' Cancer Test Results That Sent Revolution Medicines Flying
Tango Therapeutics stock hits 52-week high at $17.64
Stifel raises Tango Therapeutics stock price target on PRMT5 data
Tango Therapeutics: I'm Not Buying Into Latest Rally, Despite PRMT5 Promise (NASDAQ:TNGX)
TNGX Stock Hits Record High on Inking Collaboration Deal With ERAS
Jefferies raises Tango Therapeutics stock price target on RAS deal
Tango Therapeutics, Up 39% This Year, Surges Again On Another Cancer Pact
Stifel reiterates Tango Therapeutics stock Buy rating at $15
Tango Therapeutics stock hits 52-week high at $13.66